• Company Type For Profit
  • Contact Email PR@intrapace.com
  • Phone Number (650) 376-4070

IntraPace® has developed a novel implantable system to treat obesity. It is built on the proven technology used in millions of cardiac pacemakers and defibrillators each year. The abiliti® system is designed to be implanted via standard laparoscopic instruments without making any changes to the anatomy of the digestive system or placing any

limitations on what a person can eat or drink.

Lists Featuring This Company

Silicon Valley Companies With More Than 10 Employees (Top 10K)
9,963 Number of Organizations • $491.1B Total Funding Amount • 27,438 Number of Investors
Silicon Valley Biotechnology Companies
986 Number of Organizations • $70B Total Funding Amount • 3,141 Number of Investors
California Health Diagnostics Companies
1,941 Number of Organizations • $53.5B Total Funding Amount • 2,476 Number of Investors
California Health Care Companies (Top 10K)
9,992 Number of Organizations • $268.3B Total Funding Amount • 18,107 Number of Investors

Frequently Asked Questions

Where is Intrapace's headquarters? Intrapace is located in San Jose, California, United States.Who invested in Intrapace? Intrapace has 10 investors including The Halo Fund and The Angels' Forum.How much funding has Intrapace raised to date? Intrapace has raised .When was the last funding round for Intrapace? Intrapace closed its last funding round on Aug 26, 2013 from a Venture - Series Unknown round.Who are Intrapace's competitors? Alternatives and possible competitors to Intrapace may include Intarcia TherapeuticsRadius Health, and Lucira Health.